progesterone-optimized-for-treating-brain-injuryResearchers are moving ahead by testing progesterone in the quest to optimizing the effectiveness of the hormone for treating traumatic brain injury.

In this direction, two abstracts summarizing Emory research on the hormone were presented at the 2009 Society for Neuroscience (SFN) meeting in Chicago.

A multisite phase III clinical trial called ProTECT III will be initiated for examining the effectiveness of the hormone in the coming few months. The trial was developed by Donald Stein, PhD, Asa G. Candler Professor of Emergency Medicine at Emory School of Medicine.

It was noted by the authors that a low amount of Vitamin D has the ability to boost progesterone’s ability to guard neurons from excito-toxicity, which is a principal cause of brain injury and cell death.